INCY NASDAQ Week ended 18 Sep 2026

Weekly Investor Report

Incyte Corporation · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 125.31 USD
3.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 16.8% above the Trend Line and sits at 85.8% of its 52-week range. The latest completed week returned 3.2%, after a -2.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 42/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: earnings are due in 34d.

Setup score 61 out of 100
Latest Close 125.31 USD 18 Sep 2026
1W Return 3.2% latest completed week
4W Return -2.0% short-term follow-through
12W Return 10.2% quarterly tape
Trend Breadth 71.2% 37 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 12-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 16 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.2% Latest completed week; four-week move -2.0%. Indicator stack 81/61 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 42/100 conviction; expected move 8.5%. News sentiment 55/100 56 relevant articles in the latest sentiment read. Event risk 34d Next report is scheduled for 27 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 16.8% above the Trend Line and sits at 85.8% of its 52-week range. The latest completed week returned 3.2%, after a -2.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug 21 Aug 28 Aug 4 Sep 11 Sep 18 Sep
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9312-week average 0.73

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.93Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1616 reversal markers

No recent accumulation markers. 16 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.0% over four weeks, 10.2% over 12 weeks, and 44.8% over one year. The current trend has remained active for 12 consecutive weeks.

Performance by holding period

1W3.2%
4W-2.0%
12W10.2%
26W38.0%
52W44.8%
Active trend streak12 weeks
Active weeks in one year37
Trend breadth71.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.77Latest activity-pressure read.
Pressure change-34.3%Four-week change in activity pressure.
Leadership9.07Latest relative-leadership reading.
RS change-35.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 18 Sep 2026 Financial statements through 30 Jun 2026 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength94/100Blend of value, momentum, and quality. Underlying universe rank 7; rank 1 is best.
Value70/100Relative valuation strength. Underlying universe rank 31; rank 1 is best.
Quality100/100Profitability and accounting quality. Underlying universe rank 1; rank 1 is best.
Momentum91/100Medium-term price momentum. Underlying universe rank 10; rank 1 is best.
Growth95/100Revenue and earnings growth. Underlying universe rank 6; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework84/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
15.8x
Price divided by trailing earnings.
Price / sales
4.4x
Market value relative to trailing revenue.
EV / EBITDA
11.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
92.6%
Gross profit retained from each unit of revenue.
Operating margin
31.6%
Operating profit retained from revenue.
Free-cash-flow margin
33.0%
Free cash flow generated from revenue.
Return on invested capital
62.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
26.9%
Latest one-year revenue growth.
EPS growth
85.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
103.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-1.5%
Net share repurchases relative to market value.
Shareholder yield
-1.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-2.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

INCY shows bullish options pressure with a 42/100 conviction score, put-call volume ratio of 0.20, expected move of 8.5%, and Sharemaestro trend signal active.

Conviction42/100
Expected move8.5%
Put/call volume0.20
Pressure57
Speculation8
Volatility61
Trend agreement38
Open options detail
Insider activity6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 56 relevant articles.

22 positive · 31 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings34dNext report is scheduled for 27 Oct 2026; event risk rises as the date approaches.
Options expected move8.5%Nearest-chain priced movement where available.
52-week drawdown-5.5%Distance below the 52-week high.
13-week volatility4.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+15.8%Week of 26 Jun.
Worst week-9.5%Week of 19 Jun.
Latest week+3.2%Week of 18 Sep.

Shape of recent returns

Strong gains5
Modest gains12
Flat weeks0
Modest losses7
Sharp losses2
Recent vol4.7%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape63/100

Trend, activity pressure, participation, and risk combine to a 63/100 tape read.

 Indicator analysis82/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.93; 16 reversal markers Factors88/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 85 SVQF84/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 120.0 of 748 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options53/100

INCY shows bullish options pressure with a 42/100 conviction score, put-call volume ratio of 0.20, expected move of 8.5%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 8.5% Sentiment55/100

Weighted news tone is neutral across 56 relevant articles.

Incyte's Colorectal Cancer Program Remains Risky, Long-Term, RBC Says Insiders6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

 Earnings34d

Next report is scheduled for 27 Oct 2026; event risk rises as the date approaches.

 Research flow4 items

3 recent research articles and 1 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
18 Sep 2026125.31 USD3.2%107.24 USD77.73 USD0.779.079.5MOn
11 Sep 2026121.47 USD-4.2%106.44 USD77.30 USD0.907.075.5MOn
4 Sep 2026126.75 USD1.9%105.76 USD76.93 USD1.0111.466.9MOn
28 Aug 2026124.37 USD-2.7%105.15 USD76.52 USD1.0410.094.7MOn
21 Aug 2026127.81 USD6.4%104.34 USD76.14 USD1.1813.967.4MOn
14 Aug 2026120.16 USD-0.3%103.48 USD75.73 USD1.104.945.1MOn
7 Aug 2026120.56 USD0.9%103.02 USD75.37 USD1.196.639.2MOn
31 Jul 2026119.52 USD1.6%102.56 USD75.02 USD1.1611.5016.0MOn
24 Jul 2026117.67 USD0.4%101.96 USD74.66 USD1.0810.886.3MOn
17 Jul 2026117.25 USD0.5%101.37 USD74.31 USD1.209.377.9MOn
10 Jul 2026116.71 USD-0.1%100.89 USD73.97 USD1.074.967.8MOn
3 Jul 2026116.86 USD2.7%100.18 USD73.62 USD1.117.497.7MOn
26 Jun 2026113.75 USD15.8%99.70 USD73.27 USD1.036.0711.5MOff
19 Jun 202698.22 USD-9.5%99.39 USD72.94 USD0.60-12.1310.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context